Skip to content

Hematology

Economic Outcomes

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

Source‎: Anaesthesia 2019;74(12):1534-41.

Indexed‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Source‎: Blood Adv. 2022;6(3):785-92.

Indexed‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (opens new window)

HEMATOLOGY
Economic Outcomes
English
Economic Outcomes
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Contact

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

View Downloads

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

View Videos